Faeth Therapeutics (FTH) Balance Sheet: Assets & Liabilities

Faeth Therapeutics (FTH) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Faeth Therapeutics reported total assets of $22.90M and total liabilities of $4.31M. Shareholders' equity was $18.59M, down 51.6% from $38.39M a year earlier. Total debt stood at $1.51M against $21.18M in cash and short-term investments, a net cash position of $19.68M. That puts debt-to-equity at 0.08, compared with 0.10 a year earlier.

Faeth Therapeutics Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Faeth Therapeutics, Inc. (FTH) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	8.67	9.99	13.01	17.80	7.16	16.60	0.25	0.65
Short-Term Investments	12.52	31.34	52.75	89.32	140.46	0.00	0.00	0.00
Cash & Short-Term Investments	21.18	41.34	65.76	107.12	147.62	16.60	0.25	0.65
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.32	0.59	1.49	1.47	0.92	3.48	0.25	0.63
Total Current Assets	21.51	41.93	67.25	108.59	148.54	20.08	0.50	1.28
Non-Current Assets
Property, Plant & Equipment (Net)	1.38	3.38	7.04	9.72	4.64	1.27	0.27	0.12
Other Non-Current Assets	0.02	0.05	0.09	0.06	0.04	0.09	0.45	0.45
Total Non-Current Assets	1.40	3.43	7.12	9.79	4.68	1.35	0.72	0.57
Total Assets	22.90	45.36	74.37	118.38	153.23	21.43	1.22	1.85
Current Liabilities
Accounts Payable	0.69	0.24	1.69	4.47	2.46	3.88	3.45	1.11
Short-Term Debt	1.45	2.32	2.44	2.13	0.68	0.03	16.06	0.70
Accrued Liabilities	2.80	3.13	3.20	6.94	4.21	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.00	2.08	0.65
Other Current Liabilities	2.11	2.89	1.51	2.46	1.75	0.92	0.13	0.86
Total Current Liabilities	4.25	5.45	5.64	9.07	4.89	4.83	21.71	2.66
Non-Current Liabilities
Long-Term Debt	0.06	1.53	3.77	5.90	1.67	0.65	0.00	4.05
Other Non-Current Liabilities	0.00	0.00	0.07	0.00	0.15	0.05	48.17	48.62
Total Non-Current Liabilities	0.06	1.53	3.84	5.90	1.82	0.71	48.17	52.67
Total Liabilities	4.31	6.98	9.48	14.97	6.71	5.54	69.88	55.33
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-283.14	-262.05	-231.90	-197.79	-149.21	-112.41	-92.31	-75.57
Accumulated Other Comprehensive Income	0.00	-0.01	-0.21	-1.00	-0.33	0.00	0.00	-0.31
Additional Paid-in Capital	301.73	300.45	297.00	302.20	296.05	55.97	-23.89	-25.14
Shares Outstanding	1.26	1.26	1.25	1.54	-	-	-	-
Total Stockholders' Equity	18.59	38.39	64.90	103.41	146.51	15.89	-68.66	-53.48
Total Liabilities & Equity	22.90	45.36	74.37	118.38	153.23	21.43	1.22	1.85

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Faeth Therapeutics Balance Sheet

How much debt does Faeth Therapeutics have?

Faeth Therapeutics had total debt of $1.51M as of Dec 31, 2025, against $21.18M in cash and short-term investments. Its debt-to-equity ratio was 0.08. Total debt was $3.85M a year earlier.

What are Faeth Therapeutics's total assets?

Faeth Therapeutics reported total assets of $22.90M as of Dec 31, 2025, down 49.5% from $45.36M a year earlier. Total liabilities were $4.31M.

What is Faeth Therapeutics's shareholders' equity?

Faeth Therapeutics's shareholders' equity was $18.59M as of Dec 31, 2025, or about $14.74 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition